NCT02411201 - DOTAREM Pharmacokinetics and Safety Study in Pediatric Subjects Aged < 2 Years | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions

Magnetic Resonance Imaging

Interventions

DRUG

DOTAREM

Single intravenous injection of 0.1 mmol/kg body weight

Trial Locations (9)

Department of Molecular and Neurological Clinical and Research Center, Budapest

Borsod-Abaúj-Zemplén University County Hospital, Miskolc

Landes-Frauen-und Kinderklinik Linz, Linz

University of Debrecen Medical Center, Debrecen

Uniwersytecki Szpital Dziecięcy w Lublinie, Lublin

CHU, Bordeaux

CHRU, Lille

Hôpital de Hautepierre, Strasbourg

Instytut Pomnik -Centrum Zdrowia Dziecka, Warsaw